Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
20
NGVT Quote, Financials, Valuation and Earnings
Last price:
$32.94
Seasonality move
:
5.04%
Day range:
$31.91 - $33.09
52-week range:
$28.49 - $56.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.85x
P/B ratio:
6.16x
Volume:
232.3K
Avg. volume:
273.5K
1-year change:
-35.51%
Market cap:
$1.2B
Revenue:
$1.4B
EPS (TTM):
-$11.84
Earnings Data
Next earnings date for NGVT
May 06
2025
Most recent earnings per share
$0.46
Beat by $0.15
(Feb 18/2025)
Consensus Estimate
$0.31
(Feb 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NGVT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $385.4M | -- | -- | $1.30 | -- |
| 05/06/2025 | Q1 | $285.5M | -- | -- | $0.74 | -- |
| 02/18/2025 | Q4 | $297.4M | $298.8M | $0.46 | $0.31 | $0.15 |
| 10/29/2024 | Q3 | $377M | $376.9M | -$2.95 | $0.88 | -$3.83 |
| 07/31/2024 | Q2 | $401.7M | $390.6M | -$7.81 | $1.04 | -$8.85 |
| 05/01/2024 | Q1 | $319.2M | $340.1M | -$1.54 | $0.25 | -$1.79 |
| 02/21/2024 | Q4 | $332.6M | $371.7M | -$3.23 | -$0.19 | -$3.04 |
| 11/01/2023 | Q3 | -- | -- | $0.69 | $1.23 | -$0.54 |
| 08/02/2023 | Q2 | -- | -- | $0.97 | $1.38 | -$0.41 |
| 05/03/2023 | Q1 | -- | -- | $1.35 | $1.11 | $0.24 |
| 02/27/2023 | Q4 | -- | -- | $0.41 | $0.87 | -$0.46 |
| 11/02/2022 | Q3 | -- | -- | $1.98 | $1.69 | $0.29 |
| 08/02/2022 | Q2 | -- | -- | $1.54 | $1.62 | -$0.08 |
| 05/04/2022 | Q1 | -- | -- | $1.55 | $1.04 | $0.51 |
| 02/23/2022 | Q4 | -- | -- | $0.74 | $0.78 | -$0.04 |
| 10/27/2021 | Q3 | -- | -- | -$0.11 | $1.54 | -$1.65 |
| 07/28/2021 | Q2 | -- | -- | $1.10 | $1.32 | -$0.22 |
| 04/28/2021 | Q1 | -- | -- | $1.20 | $1.03 | $0.17 |
| 02/10/2021 | Q4 | -- | -- | $1.23 | $0.77 | $0.46 |
| 10/28/2020 | Q3 | -- | -- | $1.69 | $1.01 | $0.68 |
| 07/29/2020 | Q2 | -- | -- | $0.49 | $0.60 | -$0.11 |
| 04/29/2020 | Q1 | -- | -- | $1.08 | $0.82 | $0.26 |
| 02/19/2020 | Q4 | -- | -- | $1.05 | $1.07 | -$0.02 |
| 10/23/2019 | Q3 | -- | -- | $1.41 | $1.40 | $0.01 |
| 07/24/2019 | Q2 | -- | -- | $1.36 | $1.33 | $0.03 |
| 05/01/2019 | Q1 | -- | -- | $0.99 | $0.98 | $0.01 |
| 02/13/2019 | Q4 | -- | -- | $1.07 | $0.77 | $0.30 |
| 10/24/2018 | Q3 | -- | -- | $1.16 | $1.04 | $0.12 |
| 07/25/2018 | Q2 | -- | -- | $1.12 | $1.00 | $0.12 |
| 05/02/2018 | Q1 | -- | -- | $0.79 | $0.63 | $0.16 |
| 02/20/2018 | Q4 | -- | -- | $0.45 | $0.36 | $0.09 |
| 11/01/2017 | Q3 | -- | -- | $0.86 | $0.76 | $0.10 |
| 08/02/2017 | Q2 | -- | -- | $0.78 | $0.70 | $0.08 |
| 05/04/2017 | Q1 | -- | -- | $0.49 | $0.47 | $0.02 |
| 02/23/2017 | Q4 | -- | -- | $0.34 | $0.30 | $0.04 |
Ingevity Earnings Questions
-
How Much did Ingevity Generate in Revenue Last Quarter?
Ingevity reported $298.8M worth of top line sales in its most recent quarter.
-
Did Ingevity Beat Earnings Last Quarter?
Ingevity announced earnings per share of $0.46 which represents a beat of analyst forecast a $0.31 per share.
-
Is Ingevity Profitable?
Ingevity reported $101.9M that represents $2.80 per share over the last quarter.
-
What is the Analyst Consensus for Ingevity EPS Next Year?
Ingevity's earnings are forecast to decrease from -$11.85 per share to $2.93 per share next year representing a decrease of -35.22%.
-
When is Ingevity's Earnings Date?
Ingevity's next earnings date is May 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
20
EVVTY alert for May 1
Evolution AB [EVVTY] is down 19.01% over the past day.
Sell
47
LANC alert for May 1
Lancaster Colony [LANC] is down 15.56% over the past day.
Sell
36
BHE alert for May 1
Benchmark Electronics [BHE] is down 15.02% over the past day.
